Convergence Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Convergence Financial's PFE Position: Q2 2026 in Review
Convergence Financial opened a new position in Pfizer (PFE) in Q2 2026: 11,086 shares worth $267K. The stake represents 0.02% of the portfolio and ranks #233 among its holdings. This is a return to the name: Convergence Financial previously reported a position in PFE as recently as Q1 2025.
Convergence Financial first reported a position in PFE in Q2 2024 and has held it in 5 quarters since. The position peaked at $483K in Q2 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Convergence Financial held 11,086 shares of Pfizer worth $267K as of Q2 2026.
- Pfizer was a new Convergence Financial position in Q2 2026.
- Pfizer made up 0.02% of Convergence Financial's portfolio in Q2 2026, its #233 holding.
- Convergence Financial first reported a position in Pfizer in Q2 2024 and has held it in 5 quarters since.
- Convergence Financial's Pfizer position peaked at $483K in Q2 2024.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.